Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
1st New Schizophrenia Drug in Decades
FDA Approves groundbreaking drug for schizophrenia treatment
On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way. Cobenfy (xanomeline and trospium chloride) capsules are the first antipsychotic drug approved to target cholinergic receptors. All other treatments available for schizophrenia target the dopamine receptors.
Cobenfy: The First New Schizophrenia Drug in Decades
The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other antipsychotics.
FDA Approves the First New Schizophrenia Drug in Decades
Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely different way from existing medications for schizophrenia, which is building excitement and enthusiasm among doctors and patients alike.
Valley News Live
1d
FDA approves new drug for schizophrenia, described as a potential ‘game changer’
FARGO, N.D. (Valley
News
Live) - Changes are coming to the way
schizophrenia
is treated. The US Food and
Drug
...
BioSpace
6h
The Making of BMS’ Cobenfy: From Alzheimer’s to Schizophrenia
From Eli Lilly to Karuna Therapeutics to current owner Bristol Myers Squibb, the newly approved schizophrenia drug had quite ...
Onlymyhealth
16h
Breakthrough Schizophrenia Drug Offers Hope with Fewer Side Effects
New schizophrenia drug Cobenfy offers hope with fewer side effects targeting symptoms more effectively than traditional ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Iran launches missile attack
Tony-winning star dies
Helene wreaks havoc
How to watch VP debate
Kentucky sheriff steps down
Broadway star dies at 70
Explosive devices found
FL homeless law kicks in
Pledges support for Ukraine
Settlement checks delayed
Top Adams aide resigns
Jimmy Carter turns 100
'Pled guilty to journalism'
TX fraud probe shut down
Wausau drop box replaced
CA bans legacy admissions
To lay off 2,900 employees
Arkansas sues YouTube
Japan's new prime minister
More troops to Middle East
US sanctions settler group
Breast cancer deaths fall
Asylum restrictions extended
Gonzaga set to join PAC-12
194K Jeep SUVs recalled
FCC probing outage
GA abortion ban blocked
Related topics
Cobenfy
KarXT
FDA
Bristol-Myers Squibb
Feedback